Plasma homocysteine and retinal artery occlusive disease: A case-control study

Annals of Saudi Medicine

Volumn 24, Issue 3, 2004, Pages 186-188

  Narin, Figen ^a   Narin, Nazmi ^a   Halici, Canan ^a   Oner, Ayse Ozturk ^a   Dogan, Hakki ^a   Karakukcu, Musa ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Atherosclerosis; Homocysteinemia; Retinal artery occlusion

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3142768553     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.186     Document Type: Article

References (16)

1. Bakker RC, Brandjes DPM. Hyperhomocysteinemia and associated disease. Pharm World Sci. 1996;19: 126-132.
2. Heijer MD, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:12.
3. Masser PA, Taylor LM, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis. Ann Thorac Surg. 1994;58:1240-1246.
4. Malinow MR. Plasma homocysteine: A risk factor for arterial occlusive disease. J Nutr. 1996;126:1238s-1243s.
5. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay and cysteine in a clinical laboratory setting. Clin Chem. 1999;45:290-292.
6. James GK, Jones MW, Pudek KR. Homocysteine levels in patients on phenytoin therapy. Clin Biochem. 1997;30:647-649.
7. Robinson K, Mayer E, Jacobsen DW. Homocysteine and coronary disease. Cleve Clin J Med. 199;61:438-450.
8. Dudman NPH, Wilcken DEL, Wang JF, et al. Disordered methionine/homocysteine metabolism in premature vascular disease. Arterioscler Thromb. 1993;13:1253-1260.
9. Klein R, Klein BE, Moss SE, Meuer BM. Retinal emboli and cardiovascular disease. The Beaver Dam Eye Study. Arch Ophthalmol. 2002;L21:495-500.
10. Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 2000;84:154-157.
11. Wenzler EM, Rademakers AJ, Boers GM, et al. Hyper-homocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol. 1993;115:162-167.
12. Biousse V, Newman NJ, Sternberg P Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am J Ophthalmol. 1997;124:257-260.
13. Vine AK. Hyperhomocysteinemia:a risk factor for retinal vein occlusion. Am J Ophthalmol. 2000;129: 640-644.
14. Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol. 2002;12: 495-500.
15. Selhub J, Jacques PF, Wilson PWF et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
16. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum Vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136:1136-1150.